Lumiphore develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. These include biological detection systems based on luminescent lanthanide complexes (which provide a unique combination of sensitivity, reliability, flexibility and high throughput) and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics.

Excitation induced long-lived green luminescence exhibited by one of Lumiphore’s terbium complexes.

Read more about this »

A 3-dimensional representation of the complex which gives rise to the green luminescence.

Read more about this »

Algeta and Lumiphore Announce Further Expansion of their Global Partnership for the Development of Targeted Alpha-Pharmaceutical Cancer Therapeutics and Companion Diagnostics.
Lumiphore Announce Brahms diagnostic launch in Europe
Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-pharmaceutical Therapeutics
BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic Tests
Cisbio Bioassays Honored with the 2009 Frost & Sullivan North America Technology Innovation of the Year Award
Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board